This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Should You Buy It: Varian's a Buy

Shares of Varian (VARI) have recently tested investors patience. (Editor's note: this stock is not to be confused with Varian Medical Systems or Varian Semiconductor.). The company's stock has fallen 10+% since the company reported better than expected fiscal second quarter (ended March) results. The stock is down 37% lower from its October highs.

Varian makes scientific instruments such as spectroscopy systems and high-vacuum pumps that are used in chemical analysis, biomedicine and materials research. Some of Varian's larger customers include Dow Chemical (DOW), Monsanto (MON), Pfizer (PFE) and Procter & Gamble (PG).

The question is, should you buy it? Does Varian offer value following its recent pullback, or should investors focus elsewhere?

Back on April 23, Varian posted quarterly earnings of 71 cents a share, which was a nickel ahead of the consensus analyst estimate. Revenue grew 8% year-over-year to $248.2 million, which also was $1.5 million higher than expected.

Sales in both the life sciences and industrial divisions rose from a year ago, as did sales in every major geographic region. The company ended the quarter with a strong order backlog, as its customers continue to spend on research and development (R&D) to generate their own new products. Varian is also insulated from a slowing US economy, as roughly 70% of sales are generated outside of the U.S.

Varian's earnings could have been even higher in the quarter, though management increased spending for several new expected product launches in the upcoming quarters. As a result of these new items, management is targeting 5-7% organic revenue growth in fiscal 2008 (ending September).

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,113.54 +61.81 0.36%
S&P 500 1,983.53 +9.90 0.50%
NASDAQ 4,456.0160 +31.3120 0.71%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs